Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-11-28Clinical Trial Update: A Clinical Trial Evaluating a Probiotic Emollient for the Treatment of Pediatric Atopic Dermatitis [NA]
Sponsor Biogaia New Sciences AB is conducting a clinical trial to evaluate a probiotic emollient for pediatric atopic dermatitis, currently …
-
CLINICAL_TRIALS withdrawal · 2025-11-28Clinical Trial Update: Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab [Phase 4]
A Phase 4 clinical trial evaluating growth and bone mineral density in children with atopic dermatitis treated with dupilumab has been withd…
-
CLINICAL_TRIALS research · 2025-11-25Clinical Trial Update: Michigan Food and Atopic Dermatitis (M-FAD) Program - Molecular Analytics Project [NA]
University of Michigan's Michigan Food and Atopic Dermatitis (M-FAD) Program – Molecular Analytics Project is a recruiting clinical study fo…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: The Efficacy of Patients With Moderate to Severe Atopic Dermatitis Treated With Chinese Herbal Medicine [Phase 3]
A Phase 3 trial assessing the efficacy of a Chinese Herbal Medicine formulation for moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study Evaluating Rocatinlimab in Moderate-to-severe Atopic Dermatitis (ROCKET-IGNITE) [Phase 3]
Phase 3 ROCKET-IGNITE trial evaluating Rocatinlimab for moderate-to-severe atopic dermatitis has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial evaluating subcutaneous amlitelimab monotherapy versus placebo in participants aged 12 years and older with moderate-to-severe…
-
CLINICAL_TRIALS trial_result · 2025-11-24Clinical Trial Update: A Study Assessing Rocatinlimab in Combination With Topical Corticosteroid and/or Topical Calcineurin Inhibitors in Adult Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
A Phase 3 clinical trial evaluating rocatinlimab in combination with topical corticosteroids and/or topical calcineurin inhibitors for adult…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort [NA]
A clinical trial comparing broadband versus narrowband phototherapy for eczema (atopic dermatitis) within the CACTI cohort has been terminat…
-
CLINICAL_TRIALS trial_result · 2025-11-21Clinical Trial Update: Safety, Tolerability and PK of ATTO-3712 in Healthy Volunteers and Patients With Atopic Dermatitis [Phase 1]
A Phase 1 study to assess safety, tolerability, and pharmacokinetics of ATTO-3712 in healthy volunteers and subjects with atopic dermatitis;…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Effect of EMD Protocol for Urge on Dermatology-specific Quality of Life [NA]
Clinical trial update noting the completion of a study evaluating the EMD Protocol for Urge and its effect on dermatology-specific quality o…
-
CLINICAL_TRIALS trial_result · 2025-11-20Clinical Trial Update: Allergic Disease Onset Prevention Study [Phase 1, Phase 2]
Siolta Therapeutics reports completion of Phase 1 and Phase 2 for the Allergic Disease Onset Prevention Study, investigating prevention stra…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD) [Phase 1]
Clinical trial update for BBT001 evaluating healthy volunteers and adults with moderate to severe atopic dermatitis in a Phase 1 study; curr…
-
CLINICAL_TRIALS research · 2025-11-20Clinical Trial Update: A Phase I Clinical Trial to Evaluate CU-10101 Unguent [Phase 1]
This document reports a Phase I clinical trial of CU-10101 Unguent for atopic dermatitis, with enrollment by invitation currently ongoing.
-
CLINICAL_TRIALS trial_result · 2025-11-19Clinical Trial Update: NiPPeR Randomised Trial - Child Follow Up Study [NA]
The NiPPeR randomized trial child follow-up study has completed, evaluating the impact of early-life nutrition on obesity, metabolic and gro…
-
CLINICAL_TRIALS research · 2025-11-18Clinical Trial Update: Evaluation of 611 in Chinese Adolescents With Moderate to Severe Atopic Dermatitis [Phase 3]
A Phase 3 clinical trial evaluating 611 in Chinese adolescents with moderate to severe atopic dermatitis is currently recruiting. The study …
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults [Phase 1]
A Phase 1 pharmacokinetic study to assess how different forms of PF 08049820 are absorbed into the bloodstream in healthy adults, with Atopi…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD) [Phase 1]
A Phase 1 clinical trial evaluating the safety and tolerability of BBT001 in healthy volunteers and adults with Atopic Dermatitis, currently…
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis. [Phase 2]
A Phase 2 long-term study (AtDvance) evaluating GSK1070806 for atopic dermatitis has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-11-17Clinical Trial Update: A Dose Finding Study to Investigate the Safety and Effectiveness of GSK1070806 in Adult Participants With Moderate to Severe Atopic Dermatitis [Phase 2]
This Phase 2 dose-finding trial of the investigational drug GSK1070806 in adults with moderate-to-severe atopic dermatitis has been terminat…
-
CLINICAL_TRIALS research · 2025-11-17Clinical Trial Update: A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis. [Phase 2]
A Phase 2 long-term safety and efficacy study evaluating CM512 in Atopic Dermatitis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis [Phase 4]
Phase 4 trial update presents immunogenetic profiling data for dupilumab in atopic dermatitis. Results of the biomarker analyses have been p…
-
CLINICAL_TRIALS trial_result · 2025-11-06Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of IMG-007 in Adults With Atopic Dermatitis (AD) [Phase 1, Phase 2]
A Phase 1/2 study evaluating IMG-007 in adults with atopic dermatitis was terminated, with results posted for safety, pharmacokinetics, and …
-
CLINICAL_TRIALS research · 2025-11-06Clinical Trial Update: Ethnic Differences in Mechanisms of Action of Dupilumab [Phase 4]
Phase 4 clinical trial at University of Michigan is investigating ethnic differences in dupilumab's mechanisms of action for atopic dermatit…
-
CLINICAL_TRIALS trial_result · 2025-11-05Clinical Trial Update: A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER) [Phase 3]
Amgen completed a Phase 3 trial (ROCKET-VOYAGER) evaluating rocatinlimab’s impact on vaccine antibody response in patients with moderate-to-…
-
CLINICAL_TRIALS other · 2025-11-03Clinical Trial Update: A Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD) [Phase 3]
Phase 3 clinical trial update evaluating long-term safety, tolerability, and efficacy of Rocatinlimab in adults and adolescents with moderat…